SEELOS THERAPEUTICS, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Seelos Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2024.
  • Seelos Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 3.32M shares, a 97.3% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 3.32M -121M -97.3% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 15.3M -107M -87.5% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 1.22M -2.35M -65.7% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 160M +52.3M +48.8% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 124M +18M +16.9% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 122M +16.2M +15.4% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 3.57M -102M -96.6% Dec 31, 2022 10-K 2024-03-06
Q3 2022 107M +4.81M +4.7% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 106M +3.92M +3.83% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 106M +27.3M +34.9% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 106M +51M +93.5% Dec 31, 2021 10-K 2023-03-10
Q3 2021 102M +49.1M +92.1% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 102M +57.9M +130% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 78.3M +34.3M +77.9% Mar 31, 2021 10-Q 2021-04-30
Q4 2020 54.5M +27.5M +102% Dec 31, 2020 10-K 2022-03-04
Q3 2020 53.3M +26.3M +97.7% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 44.4M +23.1M +109% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 44M +23.8M +118% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 27M +23.9M +777% Dec 31, 2019 10-K 2021-03-11
Q3 2019 26.9M -1.19M -4.22% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 21.3M -2.16M -9.23% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 20.2M +3.87M +23.7% Mar 31, 2019 10-Q 2019-05-21
Q4 2018 3.08M +2.57M +508% Dec 31, 2018 10-K 2020-03-17
Q3 2018 28.1M +13.1M +87.2% Sep 30, 2018 10-Q 2018-10-31
Q2 2018 23.4M +10.7M +83.4% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 16.3M +8.6M +111% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 507K -7.23M -93.4% Dec 31, 2017 10-K 2019-03-28
Q3 2017 15M +7.3M +94.3% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 12.8M -49.1M -79.3% Jun 30, 2017 10-Q 2017-08-02
Q1 2017 7.74M -54M -87.5% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 7.73M +2.69M +53.4% Dec 31, 2016 10-K 2018-03-01
Q3 2016 7.73M -42.7M -84.7% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 61.9M +11.5M +22.8% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 61.8M +11.4M +22.5% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 5.04M -39.3M -88.6% Dec 31, 2015 10-K 2017-03-13
Q3 2015 50.4M +10.4M +26% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 50.4M +12.3M +32.3% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 50.4M +12.6M +33.2% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 44.3M +6.79M +18.1% Dec 31, 2014 10-K 2016-03-09
Q3 2014 40M +2.49M +6.64% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 38.1M +1.12M +3.03% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 37.9M +7.5M +24.7% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 37.5M +7.6M +25.4% Dec 31, 2013 10-K 2015-03-16
Q3 2013 37.5M +7.93M +26.8% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 37M +9.99M +37% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 30.4M +3.74M +14.1% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 29.9M +8.59M +40.2% Dec 31, 2012 10-K 2014-03-17
Q3 2012 29.6M +8.94M +43.3% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 27M +6.98M +34.9% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 26.6M Mar 31, 2012 10-Q 2012-05-10
Q4 2011 21.3M +2.83M +15.3% Dec 31, 2011 10-K 2013-03-18
Q3 2011 20.7M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 20M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 18.5M Dec 31, 2010 10-K 2012-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.